{"title":"阿斯利康COVID-19疫苗接种后急性横贯脊髓炎1例","authors":"Madike Reema, L. Andrew","doi":"10.17352/2455-5282.000169","DOIUrl":null,"url":null,"abstract":"A 79-year-old man presented with gait dyspraxia approximately 2 days after receiving the first dose of the AstraZeneca COVID-19 vaccine (AZ-COVID-19-vax). He had no previous active issues and was currently on no medications.","PeriodicalId":389545,"journal":{"name":"Global Journal of Medical and Clinical Case Reports","volume":"129 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine\",\"authors\":\"Madike Reema, L. Andrew\",\"doi\":\"10.17352/2455-5282.000169\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 79-year-old man presented with gait dyspraxia approximately 2 days after receiving the first dose of the AstraZeneca COVID-19 vaccine (AZ-COVID-19-vax). He had no previous active issues and was currently on no medications.\",\"PeriodicalId\":389545,\"journal\":{\"name\":\"Global Journal of Medical and Clinical Case Reports\",\"volume\":\"129 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Global Journal of Medical and Clinical Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17352/2455-5282.000169\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Journal of Medical and Clinical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-5282.000169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
A 79-year-old man presented with gait dyspraxia approximately 2 days after receiving the first dose of the AstraZeneca COVID-19 vaccine (AZ-COVID-19-vax). He had no previous active issues and was currently on no medications.